3,4,5-Trihydroxybenzaldehyde from Geum japonicum has dual inhibitory effect on matrix metalloproteinase 9; inhibition of gelatinoytic activity as well as MMP-9 expression in TNF-α induced HASMC

Journal of Cellular Biochemistry

Volumn 105, Issue 2, 2008, Pages 524-533

  Suh, Seok Jong ^a   Kang, Jin Cho ^b   Tae, Chul Moon ^c   Chang, Hyeun Wook ^c   Park, Young Guk ^d   Kim, Cheorl Ho ^a  

^a Sungkyunkwan University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Yeungnam University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

3,4,5 Trihydroxybenzaldehyde; Human aortic smooth muscle cells; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Mitogen activated protein kinase; THBA; Tumor necrosis factor alpha

Indexed keywords

3,4,5 TRIHYDROXYBENZALDEHYDE; GELATINASE A; GELATINASE B; GEUM JAPONICUM EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG INHIBITION; GEL MOBILITY SHIFT ASSAY; GEUM; GEUM JAPONICUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

BENZALDEHYDES; GELATIN; GENE EXPRESSION REGULATION; GEUM; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCYTES, SMOOTH MUSCLE; PLANTS, MEDICINAL; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

GEUM JAPONICUM;

EID: 54849442252     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21854     Document Type: Article

References (48)

1. Abedi H, Zachary I. 1995. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 30:544-556.
2. Bain J, McLauchlan H, Elliott M, Cohen P. 2003. The specificities of protein kinase inhibitors: An update. Biochem J 371:199-204.
3. Barr RK, Kendrick TS, Bogoyevitch MA. 2002. Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 277:10987-10997.
4. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545.
5. Bond M, Fabunmi RP, Baker AH, Newby AC. 1998. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B. FEBS Lett 435:29-34.
6. Cha BY, Park CJ, Lee DG, Lee YC, Kim DW, Kim JD, Seo WG, Kim CH. 2003. Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9. J Ethnopharmacol 85:163-167.
7. Cheung WL, Cheng L, Liu H, Gu X, Li M. 2007. The dual actions of angiogenesis and anti-apoptosis induced by an isolated fraction from Geum japonicum repair muscle ischemia. Arch Biochem Biophys 459:91-97.
8. Cho A, Reidy MA. 2002. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91:845-851.
9. Cho A, Graves J, Reidy MA. 2000. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:2527-2532.
10. Chung TW, Moon SK, Lee YC, Kim JG, Ko JH, Kim CH. 2002. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch Biochem Biophys 408:147-154.
11. Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim SH, Kim JG, Kim CH. 2004. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 18:1670-1681.
12. Clausell N, de Lima VC, Molossi S, Liu P, Turley E, Gotlieb AI, Adelman AG, Rabinovitch M. 1995. Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy. Br Heart J 73:534-539.
13. De Clerck YA, Darville MI, Eeckhout Y, Rousseau GG. 1994. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139:185-191.
14. Dollery CM, McEwan JR, Henney AM. 1995. Matrix metalloproteinases and cardiovascular disease. Circ Res 77:863-868.
15. Dong H, Chen SX, Kini RM, Xu HX. 1998. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. J Nat Prod 61:1356-1360.
16. Dzwonek J, Rylski M, Kaczmarek L. 2004. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567:129-135.
17. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. 1996. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315(Pt 1): 335-342.
18. Faisal Khan KM, Falcone DJ, Kraemer R. 2002. Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 277:2353-2359.
19. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181-189.
20. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. 2002. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91:852-859.
21. Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA, Law RE. 1999. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 33:183-189.
22. Goetze S, Kintscher U, Kaneshiro K, Meehan WP, Collins A, Fleck E, Hsueh WA, Law RE. 2001. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 159:93-101.
23. Heber D. 2001. Herbs and atherosclerosis. Curr Atheroscler Rep 3:93-96.
24. Huang HC, Wang HR, Hsieh LM. 1994. Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. Eur J Pharmacol 251:91-93.
25. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J. 1997. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17:490-497.
26. Kim BJ, Kim YK, Park WH, Ko JH, Lee YC, Kim CH. 2003. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits. Int Immunopharmacol 3:723-734.
27. Kim JB, Kim JB, Cho KJ, Konig GM, Wright AD. 2006. Antioxidant activity of 3,4,5-trihydroxybenzaldehyde isolated from Geum japonicum. J Food Drug Anal 14:190-193.
28. Maeda K, Kuzuya M, Cheng XW, Asai T, Kanda S, Tamaya-Mori N, Sasaki T, Shibata T, Iguchi A. 2003. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 166:23-30.
29. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, Hawkins SM, Clowes AW. 1999. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85:1179-1185.
30. Moon SK, Cha BY, Kim CH. 2004. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J Cell Physiol 198:417-427.
31. Newby AC, Zaltsman AB. 2000. Molecular mechanisms in intimal hyperplasia. J Pathol 190:300-309.
32. Ohtsu H, Mifune M, Frank GD, Saito S, Inagami T, Kim-Mitsuyama S, Takuwa Y, Sasaki T, Rothstein JD, Suzuki H, Nakashima H, Woolfolk EA, Motley ED, Eguchi S. 2005. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arterioscler Thromb Vasc Biol 25:1831-1836.
33. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. 1992. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267:21712-21719.
34. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG., et al. 1994. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75:41-54.
35. Roderfeld M, Graf J, Giese B, Salguero-Palacios R, Tschuschner A, Muller-Newen G, Roeb E. 2007. Latent MMP-9 is bound to TIMP-1 before secretion. Biol Chem 388:1227-1234.
36. Ross R. 1986. The pathogenesis of atherosclerosis - An update. N Engl J Med 314:488-500.
37. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:801-809.
38. Ross R. 1995. Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804.
39. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. 1991. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266:7870-7875.
40. Stetler-Stevenson WG, Hewitt R, Corcoran M. 1996. Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin Cancer Biol 7:147-154.
41. Suh SJ, Jin UH, Choi HJ, Chang HW, Son JK, Lee SH, Jeon SJ, Son KH, Chang YC, Lee YC, Kim CH. 2006. Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-alpha-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-kappaB and AP-1. Biochem Pharmacol 72:1680-1689.
42. Tipping PG, Hancock WW. 1993. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 142:1721-1728.
43. Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, Midgley L, O'Regan DJ, Wood IC, Ball SG, Porter KE. 2007. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. J Mol Cell Cardiol 43: 168-176.
44. Xu HX, Zeng FQ, Wan M, Sim KY. 1996. Anti-HIV triterpene acids from Geum japonicum. J Nat Prod 59:643-645.
45. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D. 2001. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20:8066-8074.
46. Yao JS, Chen Y, Zhai W, Xu K, Young WL, Yang GY. 2004. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: The role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 95:364-371.
47. Yoshie F, Iizuka A, Kubo M, Komatsu Y, Matsumoto A, Itakura H, Takeda H, Matsumiya T, Kondo K. 2001. Protective effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Pharmacol Res 43:481-488.
48. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, Iwao H. 2003. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 23:795-801.